全球肠外营养市场规模、份额、趋势和成长分析报告（2026-2034年）

预计肠外营养市场规模将从 2025 年的 87.4 亿美元成长到 2034 年的 155.9 亿美元，2026 年至 2034 年的复合年增长率为 6.65%。

由于慢性病发病率上升以及需要营养支持的患者数量不断增加，肠外营养市场预计将迎来显着增长。随着医疗保健机构认识到合理营养对改善患者预后的重要性，对肠外营养解决方案的需求预计将会增加。该市场涵盖多种产品，包括胺基酸、脂质、碳水化合物和维生素，旨在满足经口进食困难患者的特定营养需求。人们对营养在復健和疾病管理中的作用认识不断提高，正在推动肠外营养在各种医疗机构中的应用。

肠外营养製剂和输注系统的创新也塑造着该市场的未来。针对个别患者需求（例如代谢状况和合併症）的客製化营养解决方案的开发，正在提高肠外营养的有效性。此外，输注技术的进步，包括智慧输注帮浦和自动化系统，正在提高营养输送的安全性和精确性，并降低肠外营养相关併发症的风险。随着这些技术的不断发展，预计市场产品种类将日益丰富，以满足更广泛的患者群体的需求。

此外，随着医疗机构和製药公司意识到营养支持方面尚未满足的需求，加大研发投入将对肠外营养市场产生正面影响。临床医生、营养师和相关人员之间的合作对于推广临床指南和确保肠外营养的安全有效使用至关重要。在这种不断变化的环境下，监管机构有望简化创新配方的核准流程，并加速病患获得救命营养疗法的途径。未来，人们将更加关注如何将肠外营养融入全面的患者照护策略，并强调营养在改善患者復原和整体健康方面的重要性。

目录

第一章 引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 绘製渗透率和成长前景图
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 市场问题
• 波特五力分析
• PESTLE分析

4. 全球肠外营养市场（依营养素类型划分）

• 市场分析、洞察与预测
• 碳水化合物
• 肠外脂肪乳剂
• 单剂量胺基酸製剂
• 微量元素
• 维生素和矿物质

5. 全球肠外营养市场依阶段类型划分

• 市场分析、洞察与预测
• 成人
• 儿童

6. 全球肠外营养市场（依适应症划分）

• 市场分析、洞察与预测
• 阿兹海默症
• 营养缺乏
• 癌症治疗
• 糖尿病
• 慢性肾臟病
• 罕见疾病
• 吞嚥困难
• 疼痛管理
• 吸收不良/消化系统疾病/腹泻
• 其他的

7. 全球肠外营养市场（依销售管道划分）

• 市场分析、洞察与预测
• 在线的
• 零售
• 设施

8. 全球肠外营养市场（依地区划分）

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第九章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商格局（基于现有资讯）
• 策略规划

第十章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Baxter
  • Grifols
  • Allergan
  • Otsuka Pharmaceutical Factory Inc
  • Actavis Inc
  • B. Braun Melsungen AG
  • Fresenius Kabi AG
  • Vifor Pharma
  • Sichuan Kelun Pharmaceutical Co. Ltd
  • Pfizer Inc.（Hospira Inc.）

The Parenteral Nutrition Market size is expected to reach USD 15.59 Billion in 2034 from USD 8.74 Billion (2025) growing at a CAGR of 6.65% during 2026-2034.

The parenteral nutrition market is set for significant growth, driven by the increasing prevalence of chronic diseases and the rising number of patients requiring nutritional support. As healthcare providers recognize the importance of adequate nutrition in improving patient outcomes, the demand for parenteral nutrition solutions is expected to rise. This market encompasses a range of products, including amino acids, lipids, carbohydrates, and vitamins, tailored to meet the specific nutritional needs of patients unable to consume food orally. The growing awareness of the role of nutrition in recovery and disease management is propelling the adoption of parenteral nutrition across various healthcare settings.

Innovations in parenteral nutrition formulations and delivery systems are also shaping the future of this market. The development of customized nutrition solutions that consider individual patient requirements, such as metabolic conditions and comorbidities, is enhancing the effectiveness of parenteral nutrition. Additionally, advancements in infusion technology, including smart pumps and automated systems, are improving the safety and accuracy of nutrient delivery, reducing the risk of complications associated with parenteral feeding. As these technologies continue to evolve, the market is likely to witness a diversification of product offerings that cater to a wide range of patient populations.

Furthermore, the parenteral nutrition market will benefit from increased investment in research and development, as healthcare organizations and pharmaceutical companies recognize the unmet needs in nutritional support. Collaborative efforts between clinicians, nutritionists, and industry stakeholders will be crucial in advancing clinical guidelines and ensuring the safe and effective use of parenteral nutrition. As the landscape evolves, regulatory bodies are expected to streamline approval processes for innovative formulations, facilitating faster access to life-saving nutritional therapies. The focus will increasingly shift towards integrating parenteral nutrition into comprehensive patient care strategies, emphasizing the importance of nutrition in enhancing recovery and overall health outcomes.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Nutrient Type

• Carbohydrates
• Parenteral Lipid Emulsion
• Single Dose Amino Acid Solution
• Trace Elements
• Vitamins & Minerals

By A Stage Type

• Adult
• Pediatrics

By Indication

• Alzheimer's
• Nutrition Deficiency
• Cancer Care
• Diabetes
• Chronic Kidney Diseases
• Orphan Diseases
• Dysphagia
• Pain Management
• Malabsorption/GI Disorder/Diarrhea
• Others
• ByA Sales Channel
• Online
• Retail
• Institutional

COMPANIES PROFILED

• Baxter, Grifols, Allergan, Otsuka Pharmaceutical Factory Inc, Actavis Inc, B Braun Melsungen AG, Fresenius Kabi AG, Vifor Pharma, Sichuan Kelun Pharmaceutical Co Ltd, Pfizer Inc Hospira Inc

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL PARENTERAL NUTRITION MARKET: BY NUTRIENT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Nutrient Type
• 4.2. Carbohydrates Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Parenteral Lipid Emulsion Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Single Dose Amino Acid Solution Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Trace Elements Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Vitamins & Minerals Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PARENTERAL NUTRITION MARKET: BY STAGE TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Stage Type
• 5.2. Adult Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Pediatrics Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PARENTERAL NUTRITION MARKET: BY INDICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Indication
• 6.2. Alzheimer's Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Nutrition Deficiency Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Cancer Care Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Diabetes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Chronic Kidney Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.7. Orphan Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.8. Dysphagia Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.9. Pain Management Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.10. Malabsorption/GI Disorder/Diarrhea Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.11. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PARENTERAL NUTRITION MARKET: BY SALES CHANNEL 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Sales Channel
• 7.2. Online Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Retail Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Institutional Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL PARENTERAL NUTRITION MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Nutrient Type
  • 8.2.2 By Stage Type
  • 8.2.3 By Indication
  • 8.2.4 By Sales Channel
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Nutrient Type
  • 8.3.2 By Stage Type
  • 8.3.3 By Indication
  • 8.3.4 By Sales Channel
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Nutrient Type
  • 8.4.2 By Stage Type
  • 8.4.3 By Indication
  • 8.4.4 By Sales Channel
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Nutrient Type
  • 8.5.2 By Stage Type
  • 8.5.3 By Indication
  • 8.5.4 By Sales Channel
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Nutrient Type
  • 8.6.2 By Stage Type
  • 8.6.3 By Indication
  • 8.6.4 By Sales Channel
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL PARENTERAL NUTRITION INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Baxter
  • 10.2.2 Grifols
  • 10.2.3 Allergan
  • 10.2.4 Otsuka Pharmaceutical Factory Inc
  • 10.2.5 Actavis Inc
  • 10.2.6 B. Braun Melsungen AG
  • 10.2.7 Fresenius Kabi AG
  • 10.2.8 Vifor Pharma
  • 10.2.9 Sichuan Kelun Pharmaceutical Co. Ltd
  • 10.2.10 Pfizer Inc. (Hospira Inc.)